References

  1. Zhu N, Zhang D, Wang W, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020;382(8):727–733. doi:10.1056/NEJMoa2001017.
  2. Wang C, Horby PW, Hayden FG, Gao GF. A novel coronavirus outbreak of global health concern [published correction appears in Lancet. 2020 Jan 29;:]. Lancet. 2020;395(10223):470–473. doi:10.1016/S0140-6736(20)30185-9.
  3. Liu T, Hu J, et al. Transmission Dynamics of 2019 Novel Coronavirus (2019-nCoV). The Lancet. 2020 Feb 05. Available at SSRN: doi:10.2139/ssrn.3526307. Accessed April 22, 2020.
  4. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China [published correction appears in Lancet. 2020 Jan 30;:]. Lancet. 2020;395(10223):497–506. doi:10.1016/S0140-6736(20)30183-5.
  5. Guan WJ, Ni ZY, Hu Y, et al. Clinical Characteristics of Coronavirus Disease 2019 in China [published online ahead of print, 2020 Feb 28]. N Engl J Med. 2020;NEJMoa2002032. doi:10.1056/NEJMoa2002032.
  6. Wang D, Hu B, Hu C, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China [published online ahead of print, 2020 Feb 7]. JAMA. 2020;e201585. doi:10.1001/jama.2020.1585.
  7. Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579(7798):270–273. doi:10.1038/s41586-020-2012-7.
  8. Wahba L, Jain N, Fire AZ, et al. Identification of a pangolin niche for a 2019-nCoV-like coronavirus through an extensive meta-metagenomic search. bioRxiv 2020 Feb 14. doi:10.1101/2020.02.08.939660. Accessed April 22, 2020.
  9. Lu CW, Liu XF, Jia ZF. 2019-nCoV transmission through the ocular surface must not be ignored. Lancet. 2020;395(10224):e39. doi:10.1016/S0140-6736(20)30313-5.
  10. Belser JA, Rota PA, Tumpey TM. Ocular tropism of respiratory viruses. Microbiol Mol Biol Rev. 2013;77(1):144–156. doi:10.1128/MMBR.00058-12.
  11. Rothe C, Schunk M, Sothmann P, et al. Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany. N Engl J Med. 2020;382(10):970–971. doi:10.1056/NEJMc2001468.
  12. Wax RS, Christian MD. Practical recommendations for critical care and anesthesiology teams caring for novel coronavirus (2019-nCoV) patients. Directives concrètes à l’intention des équipes de soins intensifs et d’anesthésiologie prenant soin de patients atteints du coronavirus 2019-nCoV. Can J Anaesth. 2020;67(5):568–576. doi:10.1007/s12630-020-01591-x.
  13. To KK, Tsang OT, Chik-Yan Yip C, et al. Consistent detection of 2019 novel coronavirus in saliva [published online ahead of print, 2020 Feb 12]. Clin Infect Dis. 2020;ciaa149. doi:10.1093/cid/ciaa149.
  14. Rodríguez-Morales AJ, MacGregor K, Kanagarajah S, Patel D, Schlagenhauf P. Going global - Travel and the 2019 novel coronavirus. Travel Med Infect Dis. 2020;33:101578. doi:10.1016/j.tmaid.2020.101578.
  15. Faecher RS, Thomas JE, Bender BS. Tuberculosis: a growing concern for dentistry?. J Am Dent Assoc. 1993;124(1):94–104. doi:10.14219/jada.archive.1993.0003.
  16. Nash KD. How infection control procedures are affecting dental practice today. J Am Dent Assoc. 1992;123(3):67–73. doi:10.14219/jada.archive.1992.0076.
  17. Earnest R, Loesche W. Measuring harmful levels of bacteria in dental aerosols. J Am Dent Assoc. 1991;122(12):55–57. doi:10.14219/jada.archive.1991.0187.
  18. Travaglini EA, Larato DC, Martin A. Dissemination of organisms bearing droplets by high-speed dental drills. J Prosthet Dent 1966;16:132-9. doi:10.1016/0022-3913(66)90120-X. Accessed April 22, 2020.
  19. Miller RL. Generation of airborne infection...by high speed dental equipment. J Am Soc Prev Dent. 1976;6(3):14–17.
  20. Micik RE, Miller RL, Mazzarella MA, Ryge G. Studies on dental aerobiology. I. Bacterial aerosols generated during dental procedures. J Dent Res. 1969;48(1):49–56. doi:10.1177/00220345690480012401.
  21. Miller RL, Micik RE, Abel C, Ryge G. Studies on dental aerobiology. II. Microbial splatter discharged from the oral cavity of dental patients. J Dent Res. 1971;50(3):621–625. doi:10.1177/00220345710500031701.
  22. Holbrook WP, Muir KF, Macphee IT, Ross PW. Bacteriological investigation of the aerosol from ultrasonic scalers. Br Dent J. 1978;144(8):245–247. doi:10.1038/sj.bdj.4804072.
  23. Williams GH 3rd, Pollok NL 3rd, Shay DE, Barr CE. Laminar air purge of microorganisms in dental aerosols: prophylactic procedures with the ultrasonic scaler. J Dent Res. 1970;49(6):1498+. doi:10.1177/00220345700490065701.
  24. Bentley CD, Burkhart NW, Crawford JJ. Evaluating spatter and aerosol contamination during dental procedures. J Am Dent Assoc. 1994;125(5):579–584. doi:10.14219/jada.archive.1994.0093.
  25. Peng X, Xu X, Li Y, Cheng L, Zhou X, Ren B. Transmission routes of 2019-nCoV and controls in dental practice. Int J Oral Sci. 2020;12(1):9. Published 2020 Mar 3. doi:10.1038/s41368-020-0075-9.
  26. Kenyon TA, Valway SE, Ihle WW, Onorato IM, Castro KG. Transmission of multidrug-resistant Mycobacterium tuberculosis during a long airplane flight. N Engl J Med. 1996;334(15):933–938. doi:10.1056/NEJM199604113341501.
  27. Bloch AB, Orenstein WA, Ewing WM, et al. Measles outbreak in a pediatric practice: airborne transmission in an office setting. Pediatrics. 1985;75(4):676–683.
  28. Prospero E, Savini S, Annino I. Microbial aerosol contamination of dental healthcare workers' faces and other surfaces in dental practice. Infect Control Hosp Epidemiol. 2003;24(2):139–141. doi:10.1086/502172.
  29. Araujo MW, Andreana S. Risk and prevention of transmission of infectious diseases in dentistry. Quintessence Int. 2002;33(5):376–382.
  30. Harrel SK, Molinari J. Aerosols and splatter in dentistry: a brief review of the literature and infection control implications. J Am Dent Assoc. 2004;135(4):429–437. doi:10.14219/jada.archive.2004.0207.
  31. Szymańska J. Dental bioaerosol as an occupational hazard in a dentist's workplace. Ann Agric Environ Med. 2007;14(2):203–207.
  32. Leggat PA, Kedjarune U. Bacterial aerosols in the dental clinic: a review. Int Dent J. 2001;51(1):39–44. doi:10.1002/j.1875-595x.2001.tb00816.x.
  33. Murdoch-Kinch CA, Andrews NL, Atwan S, Jude R, Gleason MJ, Molinari JA. Comparison of dental water quality management procedures. J Am Dent Assoc. 1997;128(9):1235–1243. doi:10.14219/jada.archive.1997.0400.
  34. ADA Center for Professional Success. Summary of ADA Guidance During the SARS-CoV-2 Crisis. ADA. Accessed April 22, 2020.
  35. Kilian M, Chapple IL, Hannig M, et al. The oral microbiome - an update for oral healthcare professionals. Br Dent J. 2016;221(10):657–666. doi:10.1038/sj.bdj.2016.865.
  36. King TB, Muzzin KB, Berry CW, Anders LM. The effectiveness of an aerosol reduction device for ultrasonic scalers. J Periodontol. 1997;68(1):45–49. doi:10.1902/jop.1997.68.1.45.
  37. Bennett AM, Fulford MR, Walker JT, Bradshaw DJ, Martin MV, Marsh PD. Microbial aerosols in general dental practice. Br Dent J. 2000;189(12):664–667. doi:10.1038/sj.bdj.4800859.
  38. Al Maghlouth A, Al Yousef Y, Al Bagieh N. Qualitative and quantitative analysis of bacterial aerosols. J Contemp Dent Pract. 2004;5(4):91–100. Published 2004 Nov 15.
  39. Grenier D. Quantitative analysis of bacterial aerosols in two different dental clinic environments. Appl Environ Microbiol. 1995;61(8):3165–3168.
  40. Legnani P, Checchi L, Pelliccioni GA, D'Achille C. Atmospheric contamination during dental procedures. Quintessence Int. 1994;25(6):435–439.
  41. Harrel SK, Barnes JB, Rivera-Hidalgo F. Aerosol and splatter contamination from the operative site during ultrasonic scaling. J Am Dent Assoc. 1998;129(9):1241–1249. doi:10.14219/jada.archive.1998.0421.
  42. Veena HR, Mahantesha S, Joseph PA, Patil SR, Patil SH. Dissemination of aerosol and splatter during ultrasonic scaling: a pilot study. J Infect Public Health. 2015;8(3):260–265. doi:10.1016/j.jiph.2014.11.004.
  43. Watanabe A, Tamaki N, Yokota K, Matsuyama M, Kokeguchi S. Use of ATP bioluminescence to survey the spread of aerosol and splatter during dental treatments. J Hosp Infect. 2018;99(3):303–305. doi:10.1016/j.jhin.2018.03.002.
  44. Zemouri C, de Soet H, Crielaard W, Laheij A. A scoping review on bio-aerosols in healthcare and the dental environment. PLoS One. 2017;12(5):e0178007. Published 2017 May 22. doi:10.1371/journal.pone.0178007.
  45. Volgenant CMC, de Soet JJ. Cross-transmission in the Dental Office: Does This Make You Ill?. Curr Oral Health Rep. 2018;5(4):221–228. doi:10.1007/s40496-018-0201-3.
  46. Delamater PL, Street EJ, Leslie TF, Yang YT, Jacobsen KH. Complexity of the Basic Reproduction Number (R0). Emerg Infect Dis. 2019;25(1):1–4. doi:10.3201/eid2501.171901.
  47. Chen Y, Li L. SARS-CoV-2: virus dynamics and host response [published online ahead of print, 2020 Mar 23]. Lancet Infect Dis. 2020;S1473-3099(20)30235-8. doi:10.1016/S1473-3099(20)30235-8.
  48. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study [published correction appears in Lancet. 2020 Mar 28;395(10229):1038] [published correction appears in Lancet. 2020 Mar 28;395(10229):1038]. Lancet. 2020;395(10229):1054–1062. doi:10.1016/S0140-6736(20)30566-3.
  49. Fehr AR, Perlman S. Coronaviruses: an overview of their replication and pathogenesis. Methods Mol Biol. 2015;1282:1–23. doi:10.1007/978-1-4939-2438-7_1.
  50. Gorbalenya AE, Enjuanes L, Ziebuhr J, Snijder EJ. Nidovirales: evolving the largest RNA virus genome. Virus Res. 2006;117(1):17–37. doi:10.1016/j.virusres.2006.01.017.
  51. Nakagawa K, Lokugamage KG, Makino S. Viral and Cellular mRNA Translation in Coronavirus-Infected Cells. Adv Virus Res. 2016;96:165–192. doi:10.1016/bs.aivir.2016.08.001.
  52. Fan Y, Zhao K, Shi ZL, Zhou P. Bat Coronaviruses in China. Viruses. 2019;11(3):210. Published 2019 Mar 2. doi:10.3390/v11030210.
  53. Weiss SR, Leibowitz JL. Coronavirus pathogenesis. Adv Virus Res. 2011;81:85–164. doi:10.1016/B978-0-12-385885-6.00009-2.
  54. Yin Y, Wunderink RG. MERS, SARS and other coronaviruses as causes of pneumonia. Respirology. 2018;23(2):130–137. doi:10.1111/resp.13196.
  55. Li F. Structure, Function, and Evolution of Coronavirus Spike Proteins. Annu Rev Virol. 2016;3(1):237–261. doi:10.1146/annurev-virology-110615-042301.
  56. Wu F, Zhao S, Yu B, et al. Author Correction: A new coronavirus associated with human respiratory disease in China. Nature. 2020;580(7803):E7. doi:10.1038/s41586-020-2202-3.
  57. Hantak MP, Qing E, Earnest JT, Gallagher T. Tetraspanins: Architects of Viral Entry and Exit Platforms. J Virol. 2019;93(6):e01429-17. Published 2019 Mar 5. doi:10.1128/JVI.01429-17.
  58. Belouzard S, Millet JK, Licitra BN, Whittaker GR. Mechanisms of coronavirus cell entry mediated by the viral spike protein. Viruses. 2012;4(6):1011–1033. doi:10.3390/v4061011.
  59. Wan Y, Shang J, Graham R, Baric RS, Li F. Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus. J Virol. 2020;94(7):e00127-20. Published 2020 Mar 17. doi:10.1128/JVI.00127-20.
  60. Chai X, Hu L, Zhang Y, et al. Specific ACE2 Expression in Cholangiocytes May Cause Liver Damage After 2019-nCoV Infection. bioRxiv 2020 Feb 04. doi:10.1101/2020.02.03.931766. Accessed April 22, 2020.
  61. Chen Y, Shan K, Qian W. Asians Do Not Exhibit Elevated Expression or Unique Genetic Polymorphisms for ACE2, the Cell-Entry Receptor of SARS-CoV-2. Preprints 2020, 2020020258. doi:10.20944/preprints202002.0258.v2. Accessed April 22, 2020.
  62. Peck KM, Lauring AS. Complexities of Viral Mutation Rates. J Virol. 2018;92(14):e01031-17. Published 2018 Jun 29. doi:10.1128/JVI.01031-17.
  63. Schleunes A. Relatively Stable SARS-CoV-2 Genome Is Good News for a Vaccine. The Scientist. 2020 Mar 25. Accessed April 22, 2020.
  64. Liu Y, Gayle AA, Wilder-Smith A, Rocklöv J. The reproductive number of COVID-19 is higher compared to SARS coronavirus. J Travel Med. 2020;27(2):taaa021. doi:10.1093/jtm/taaa021.
  65. Chowell G, Castillo-Chavez C, Fenimore PW, Kribs-Zaleta CM, Arriola L, Hyman JM. Model parameters and outbreak control for SARS. Emerg Infect Dis. 2004;10(7):1258–1263. doi:10.3201/eid1007.030647.
  66. Biggerstaff M, Cauchemez S, Reed C, Gambhir M, Finelli L. Estimates of the reproduction number for seasonal, pandemic, and zoonotic influenza: a systematic review of the literature. BMC Infect Dis. 2014;14:480. Published 2014 Sep 4. doi:10.1186/1471-2334-14-480.
  67. Guerra FM, Bolotin S, Lim G, et al. The basic reproduction number (R0) of measles: a systematic review. Lancet Infect Dis. 2017;17(12):e420–e428. doi:10.1016/S1473-3099(17)30307-9.
  68. National Institues of Health. News Releases. New coronavirus stable for hours on surfaces. 2020 Mar 17. Accessed April 22, 2020.
  69. Centers for Disease Control (CDC). Recommendations for preventing transmission of infection with human T-lymphotropic virus type III/lymphadenopathy-associated virus in the workplace. MMWR Morb Mortal Wkly Rep. 1985;34(45):681–695..
  70. Liu Y, Yan LM, Wan L, et al. Viral dynamics in mild and severe cases of COVID-19 [published online ahead of print, 2020 Mar 19]. Lancet Infect Dis. 2020;S1473-3099(20)30232-2. doi:10.1016/S1473-3099(20)30232-2.
  71. van Doremalen N, Bushmaker T, Morris DH, et al. Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1. N Engl J Med. 2020;382(16):1564–1567. doi:10.1056/NEJMc2004973.
  72. Backer JA, Klinkenberg D, Wallinga J. Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China, 20-28 January 2020. Euro Surveill. 2020;25(5):2000062. doi:10.2807/1560-7917.ES.2020.25.5.2000062.
  73. Cheng VCC, Wong SC, Chen JHK, et al. Escalating infection control response to the rapidly evolving epidemiology of the coronavirus disease 2019 (COVID-19) due to SARS-CoV-2 in Hong Kong [published online ahead of print, 2020 Mar 5]. Infect Control Hosp Epidemiol. 2020;1–6. doi:10.1017/ice.2020.58.
  74. Liu L, Wei Q, Alvarez X, et al. Epithelial cells lining salivary gland ducts are early target cells of severe acute respiratory syndrome coronavirus infection in the upper respiratory tracts of rhesus macaques. J Virol. 2011;85(8):4025–4030. doi:10.1128/JVI.02292-10.
  75. Kampf G, Todt D, Pfaender S, Steinmann E. Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents. J Hosp Infect. 2020;104(3):246–251. doi:10.1016/j.jhin.2020.01.022.
  76. Chen J. Pathogenicity and transmissibility of 2019-nCoV-A quick overview and comparison with other emerging viruses. Microbes Infect. 2020;22(2):69–71. doi:10.1016/j.micinf.2020.01.004
  77. Cleveland JL, Gray SK, Harte JA, Robison VA, Moorman AC, Gooch BF. Transmission of blood-borne pathogens in US dental health care settings: 2016 update. J Am Dent Assoc. 2016;147(9):729–738. doi:10.1016/j.adaj.2016.03.020.
  78. van Doremalen N, Bushmaker T, Morris DH, et al. Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1. N Engl J Med. 2020;382(16):1564–1567. doi:10.1056/NEJMc2004973.
  79. Centers for Disease Control (CDC). Recommendations for preventing transmission of infection with human T-lymphotropic virus type III/lymphadenopathy-associated virus in the workplace. MMWR Morb Mortal Wkly Rep. 1985;34(45):681–695.
  80. Centers for Disease Control (CDC). Recommendations for prevention of HIV transmission in health-care settings. MMWR Suppl. 1987;36(2):1S–18S.
  81. Centers for Disease Control (CDC). Update: universal precautions for prevention of transmission of human immunodeficiency virus, hepatitis B virus, and other bloodborne pathogens in health-care settings. MMWR Morb Mortal Wkly Rep. 1988;37(24):377–388.
  82. U.S. Department of Labor, Occupational Safety and Health Administration. 29 CFR Part 1910.1030: Occupational exposure to bloodborne pathogens—OSHA, final rule. Fed Regist. 1991;56:64004–64182. Accessed April 22, 2020.
  83. Garner JS. Guideline for isolation precautions in hospitals. The Hospital Infection Control Practices Advisory Committee [published correction appears in Infect Control Hosp Epidemiol 1996 Apr;17(4):214]. Infect Control Hosp Epidemiol. 1996;17(1):53–80. doi:10.1086/647190.
  84. Siegel JD, Rhinehart E, Jackson M, Chiarello L; Health Care Infection Control Practices Advisory Committee. 2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings. Am J Infect Control. 2007;35(10 Suppl 2):S65–S164. doi:10.1016/j.ajic.2007.10.007.
  85. Harte JA. Standard and transmission-based precautions: an update for dentistry. J Am Dent Assoc. 2010;141(5):572–581. doi:10.14219/jada.archive.2010.0232.
  86. CDC. What healthcare personnel should know about caring for patients with confirmed or possible coronavirus disease 2019 (COVID-19). Accessed April 22, 2020.
  87. CDC. oral Health. Infection Prevention & Control in Dental Settings. Summary of Infection Prevention Practices in Dental SettingsStandard Precautions. 2018 Jun 18. Accessed April 22, 2020.
  88. CDC. Coronavirus Disease 2019 (COVID-19). Healthcare Professionals. Infection Control. Dental Settings. 2020 Apr 08. Accessed April 22, 2020.
  89. ADA. ADA Interim Guidancefor Management of Emergency and Urgent Dental Care. 2020 Apr 01. Accessed April 22, 2020.
  90. EPA. Pesticide Registration. List N: Disinfectants for Use Against SARS-CoV-2. 2020 Apr 21. Accessed April 22, 2020.
  91. Wikimedia Commons. 3D medical animation corona virus. Accessed April 22, 2020.